Baker brothers report sale of Pharmion stock

By Lisa Kerner

Charlotte, N.C., Feb. 8 - Julian C. Baker and Felix J. Baker reported the sale of 36,173 shares of Pharmion Corp. stock after a series of buy and sell transactions between Dec. 20 and Jan. 23.

The shares were priced from $58.74 to $66.24, according to a schedule 13D filing with the Securities and Exchange Commission.

The investors beneficially own 2,855,271 shares, or 7.6%, of the Boulder, Colo., oncology company's common stock.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.